Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TNXPTonix Pharmaceuticals Holding Corp.

Nasdaq · CIK 0001430306
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts445

Identity from submissions API

NameTonix Pharmaceuticals Holding Corp.
CIK0001430306
TickersTNXP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN261434750
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone212-980-9155
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • TAMANDARE EXPLORATIONS INC. (2008-04-09T04:00:00.000Z → 2011-10-17T04:00:00.000Z)
Business address
200 CONNELL DRIVE, SUITE 3100
BERKELEY HEIGHTS
NJ
07922
NJ
Mailing address
200 CONNELL DRIVE, SUITE 3100
BERKELEY HEIGHTS
NJ
07922
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1521 filing rows loaded from submissions recent; extra archives: CIK0001430306-submissions-001.json (521 filings, 2008-04-09 to 2017-06-13).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 8-K 8-K 8.01 0001493152-26-051693 001-36019 261552144 34 203385 1 1
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000259 005-86436 261549256 34 8995
2026-11-12 4 4 0001493152-26-051200 6514
2026-11-09 10-Q QUARTERLY REPORT 0001999371-26-024873 001-36019 261533977 34 6704323 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001493152-26-050621 001-36019 261533806 34 311379 1 1
2026-10-15 8-K 8-K 2.02,8.01 0001493152-26-047139 001-36019 261461314 34 196913 1 1
2026-10-02 8-K 8-K 8.01 0001493152-26-045603 001-36019 261437946 34 203644 1 1
2026-09-22 8-K 8-K 8.01,9.01 0001493152-26-043644 001-36019 261395229 34 278011 1 1
2026-09-08 8-K 8-K 8.01,9.01 0001493152-26-041689 001-36019 261363356 34 250435 1 1
2026-09-08 3 3 0001493152-26-041688 9299
2026-08-31 4 4 0001493152-26-040736 6514
2026-08-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-26-018494 4941
2026-08-18 8-K 8-K 5.02,8.01 0001493152-26-039000 001-36019 261290471 34 197285 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005208 005-86436 261276446 34 11192
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001167557-26-000168 005-86436 261270349 34 8803
2026-08-10 10-Q QUARTERLY REPORT 0001999371-26-017452 001-36019 261256328 34 7170613 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001493152-26-036740 001-36019 261256189 34 347189 1 1
2026-08-03 8-K 8-K 7.01,8.01,9.01 0001493152-26-035741 001-36019 261230438 34 267098 1 1
2026-07-21 8-K 8-K 5.02 0001493152-26-034079 001-36019 261190246 34 195734 1 1
2026-07-13 8-K 8-K 7.01,8.01,9.01 0001493152-26-032925 001-36019 261169975 34 275019 1 1
2026-07-09 4 4 0001493152-26-032615 5137
2026-07-01 S-8 S-8 0001493152-26-031574 333-297204 261146279 33 1496925 1 1
2026-06-29 8-K 8-K 7.01,8.01,9.01 0001493152-26-030408 001-36019 261131289 34 268235 1 1
2026-06-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-074154 005-86436 261092157 34 15919
2026-06-15 4 4 0001493152-26-028608 4880
2026-06-09 4 4 0001493152-26-027985 5425
2026-06-09 4 4 0001493152-26-027986 7010
2026-06-08 8-K 8-K 7.01,8.01,9.01 0001493152-26-027621 001-36019 261070996 34 271608 1 1
2026-05-27 8-K 8-K 7.01,8.01,9.01 0001493152-26-025324 001-36019 261022147 34 22683475 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003484 005-86436 26988112 34 13617
2026-05-15 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-010790 001-36019 26982974 34 6561780 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003212 005-86436 26982415 34 15089
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010754 5916
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010753 5863
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010752 5900
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010751 5856
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010750 5873
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010749 5733
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010748 5899
2026-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-010747 5896
2026-05-11 8-K CURRENT REPORT 2.02,9.01 0001999371-26-010487 001-36019 26964498 34 326151 1 1
2026-05-11 10-Q QUARTERLY REPORT 0001999371-26-010486 001-36019 26964475 34 5911880 1 1
2026-05-07 8-K CURRENT REPORT 5.02,5.07,9.01 0001999371-26-010226 001-36019 26954922 34 246370 1 1
2026-05-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-010039 001-36019 26945779 34 247302 1 1
2026-05-01 8-K CURRENT REPORT 2.02,8.01 0001999371-26-009744 001-36019 26933568 34 190446 1 1
2026-04-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-009289 001-36019 26910504 34 4462106 1 1
2026-04-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-008771 001-36019 26885522 34 19268087 1 1
2026-04-01 4 xslF345X06/ownership.xml 0001999371-26-007447 6995
2026-03-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-007254 001-36019 26816863 34 13992668 1 1
2026-03-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-26-007108 001-36019 26810025 34 3262792 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002406 005-86436 26804770 34 7296
2026-03-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-006915 001-36019 26794289 34 226865 1 1
2026-03-20 PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-26-006640 001-36019 26779129 34 3208305 1 1
2026-03-18 4 xslF345X06/form4-lederman_031826.xml 0001999371-26-006235 6438
2026-03-18 8-K CURRENT REPORT 4.01,9.01 0001999371-26-006169 001-36019 26764696 34 199250 1 1
2026-03-13 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001999371-26-005744 001-36019 26750068 34 1181929
2026-03-13 8-K CURRENT REPORT 2.02,9.01 0001999371-26-005742 001-36019 26749907 34 295715 1 1
2026-03-12 10-K ANNUAL REPORT 0001999371-26-005730 001-36019 26749140 34 11413432 1 1
2026-03-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-005466 001-36019 26737279 34 235568 1 1
2026-03-03 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-26-004897 001-36019 26710945 34 213493 1 1
2026-02-26 4 xslF345X05/morris-form4_022626.xml 0001999371-26-004389 7970
2026-02-26 4 FORM 4 - SAENGER 0001999371-26-004388 7992
2026-02-26 4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004387 8015
2026-02-26 4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004386 8006
2026-02-26 4 CHANGES IN BENEFICIAL OWNERSHIP 0001999371-26-004385 8008
2026-02-17 5 xslF345X05/saenger-form5_021626.xml 0001999371-26-003371 5020
2026-02-03 8-K CURRENT REPORT 2.02,8.01 0001999371-26-002429 001-36019 26590115 34 193910 1 1
2026-01-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000297 005-86436 26582646 34 7127
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000796 005-86436 26545976 34 10866
2025-12-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005443 005-86436 251617574 34 18067
2025-12-29 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-25-021283 001-36019 251609743 34 850626 1 1
2025-12-29 424B5 PROSPECTUS SUPPLEMENT 0001999371-25-021282 333-287965 251609719 33 425014
2025-12-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-021194 001-36019 251603102 34 270274 1 1
2025-12-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-020361 001-36019 251573339 34 231251 1 1
2025-12-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-019833 001-36019 251557634 34 257833 1 1
2025-11-24 8-K CURRENT REPORT 7.01,8.01 0001999371-25-018430 001-36019 251509559 34 259287 1 1
2025-11-21 424B5 PROSPECTUS SUPPLEMENT 0001999371-25-018393 333-282270 251508700 33 35816
2025-11-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-25-018392 001-36019 251508692 34 237584 1 1
2025-11-18 8-K CURRENT REPORT 8.01 0001999371-25-018108 001-36019 251495954 34 186861 1 1
2025-11-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-017964 001-36019 251489299 34 240507 1 1
2025-11-10 10-Q QUARTERLY REPORT 0001999371-25-017370 001-36019 251466729 34 7613187 1 1
2025-11-10 8-K CURRENT REPORT 2.02,9.01 0001999371-25-017369 001-36019 251466621 34 301484 1 1
2025-10-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000328 005-86436 251439056 34 6265
2025-10-27 8-K CURRENT REPORT 2.02,8.01 0001999371-25-016108 001-36019 251417424 34 196537 1 1
2025-10-22 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-015796 001-36019 251408586 34 241007 1 1
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002913 005-86436 251402028 34 10867
2025-10-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-014776 001-36019 251378296 34 13902776 1 1
2025-09-30 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-014216 001-36019 251358237 34 229045 1 1
2025-09-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-014108 001-36019 251352362 34 4360384 1 1
2025-09-18 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-013498 001-36019 251321806 34 246413 1 1
2025-09-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-013413 001-36019 251318776 34 246709 1 1
2025-09-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002831 333-287965 251294910 33 1846
2025-09-04 S-3/A AMENDMENT TO FORM S-3 0001999371-25-012583 333-287965 251293672 33 108765
2025-09-03 CORRESP filename1.htm 0001999371-25-012501 11714
2025-09-03 CORRESP filename1.htm 0001999371-25-012500 11780
2025-08-29 CORRESP filename1.htm 0001999371-25-012337 6562
2025-08-21 4 STATEMENT OF CHANGES OF BENEFICIAL OWNERSHIP 0001999371-25-011836 4969
2025-08-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-011754 4730
2025-08-18 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-011510 001-36019 251226261 34 4455355 1 1
2025-08-15 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-011478 001-36019 251225701 34 268206 1 1
2025-08-11 8-K CURRENT REPORT 2.02,9.01 0001999371-25-011053 001-36019 251202697 34 318624 1 1
2025-08-11 10-Q QUARTERLY REPORT 0001999371-25-011050 001-36019 251202667 34 6770928 1 1
2025-07-25 8-K CURRENT REPORT 2.02,8.01 0001999371-25-009884 001-36019 251152081 34 192366 1 1
2025-07-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-009455 001-36019 251135691 34 205522 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003269 005-86436 251132448 34 10815
2025-07-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-009199 001-36019 251126141 34 10574325 1 1
2025-07-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-008900 001-36019 251114818 34 2906051 1 1
2025-07-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-008877 001-36019 251113771 34 672096 1 1
2025-07-02 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-008651 001-36019 251098320 34 238669 1 1
2025-06-16 UPLOAD filename1.pdf 0000000000-25-006293 333-287965 40205
2025-06-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-007790 001-36019 251048536 34 2379458 1 1
2025-06-13 4 HUNTER - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-007769 11892
2025-06-13 3 HUNTER - INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001999371-25-007767 5613
2025-06-13 8-K CURRENT REPORT 5.02,8.01,9.01 0001999371-25-007734 001-36019 251044727 34 232714 1 1
2025-06-12 S-3 REGISTRATION STATEMENT 0001999371-25-007635 333-287965 251041080 33 1633981
2025-06-11 424B5 PROSPECTUS SUPPLEMENT 0001999371-25-007628 333-282270 251040986 33 382773
2025-06-11 424B5 PROSPECTUS SUPPLEMENT 0001999371-25-007627 333-282270 251040983 33 325230
2025-06-11 8-K CURRENT REPORT 1.01,9.01 0001999371-25-007625 001-36019 251040955 34 1093207 1 1
2025-05-30 S-8 INITIAL REGISTRATION STATEMENT 0001999371-25-006945 333-287693 251011634 33 114536
2025-05-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-006473 001-36019 25970889 34 235551 1 1
2025-05-15 4 LEDERMAN - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006261 6355
2025-05-15 4 TRECO - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006255 5730
2025-05-15 4 BELL - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006253 5757
2025-05-15 4 TAYLOR - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006250 5756
2025-05-15 4 BAGGER - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006248 5757
2025-05-15 4 STILLWELL - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006245 5774
2025-05-15 4 OLUKOTUN - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006242 5724
2025-05-15 4 GRANGE - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-25-006236 5592
2025-05-14 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-006011 001-36019 25942599 34 238112 1 1
2025-05-12 8-K CURRENT REPORT 2.02,9.01 0001999371-25-005877 001-36019 25935604 34 287060 1 1
2025-05-12 10-Q QUARTERLY REPORT 0001999371-25-005875 001-36019 25935450 34 6008474 1 1
2025-05-08 8-K CURRENT REPORT 5.07 0001999371-25-005717 001-36019 25927408 34 251628 1 1
2025-04-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-004974 001-36019 25887437 34 1377471 1 1
2025-04-25 8-K CURRENT REPORT 2.02,8.01 0001999371-25-004807 001-36019 25875023 34 206266 1 1
2025-04-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-004623 001-36019 25863552 34 7087725 1 1
2025-04-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-004036 001-36019 25823817 34 252730 1 1
2025-04-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-003564 001-36019 25796549 34 248807 1 1
2025-03-31 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-25-003527 001-36019 25794941 34 3807980 1 1
2025-03-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-003011 001-36019 25762260 34 22314480 1 1
2025-03-21 PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-25-002999 001-36019 25761627 34 1989968 1 1
2025-03-18 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001999371-25-002792 001-36019 25749754 34 829917
2025-03-18 8-K CURRENT REPORT 2.02,9.01 0001999371-25-002787 001-36019 25749097 34 324326 1 1
2025-03-18 10-K ANNUAL REPORT 0001999371-25-002786 001-36019 25749071 34 11371810 1 1
2025-03-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-002523 001-36019 25722211 34 20284867 1 1
2025-03-04 8-K CURRENT REPORT 5.02,9.01 0001839882-25-013638 001-36019 25706684 34 516273 1 1
2025-03-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-002252 001-36019 25701502 34 8728052 1 1
2025-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-25-012474 4968
2025-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-25-012472 4943
2025-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-25-012471 4935
2025-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-25-012470 4967
2025-02-27 4 FORM 4 - SAENGER 0001839882-25-011958 9729
2025-02-27 4 FORM 4 - SULLIVAN 0001839882-25-011955 9731
2025-02-27 4 FORM 4 - LEDERMAN 0001839882-25-011952 15112
2025-02-27 4 FORM 4 - MORRIS 0001839882-25-011949 9679
2025-02-27 4 FORM 4 - FOGARTY 0001839882-25-011945 7947
2025-02-21 8-K CURRENT REPORT 8.01 0001999371-25-001802 001-36019 25648451 34 197063 1 1
2025-02-18 3 xslF345X02/fogarty-form3.xml 0001999371-25-001700 21346
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-000278 005-86436 25630672 34 7092
2025-02-07 8-K CURRENT REPORT 7.01,9.01 0001999371-25-001293 001-36019 25599465 34 241125 1 1
2025-02-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-001243 001-36019 25595529 34 21750739 1 1
2025-02-04 8-K CURRENT REPORT 5.02,7.01,8.01,9.01 0001999371-25-001136 001-36019 25585294 34 238955 1 1
2025-02-03 8-K CURRENT REPORT 1.02,2.02,3.03,8.01,9.01 0001999371-25-001105 001-36019 25580685 34 334753 1 1
2025-01-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-25-000195 001-36019 25516594 34 20816928 1 1
2025-01-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001535610-25-000014 005-86436 25505425 34 9493
2024-12-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-015671 001-36019 241569918 34 245661 1 1
2024-12-20 8-K CURRENT REPORT 8.01,9.01 0001839882-24-046555 001-36019 241568195 34 225849 1 1
2024-12-20 424B5 PROSPECTUS 0001839882-24-046554 333-266982 241568180 33 42206
2024-12-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-015450 001-36019 241553689 34 252169 1 1
2024-12-06 S-8 INITIAL REGISTRATION STATEMENT 0001839882-24-044127 333-283651 241532410 33 86180
2024-12-03 8-K/A AMENDMENT TO FORM 8-K 7.01,8.01,9.01 0001839882-24-043326 001-36019 241523702 34 47205418 1 1
2024-12-03 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-043099 001-36019 241521050 34 245376 1 1
2024-11-14 SC 13G/A armistice-tnxp093024a1.htm 0001172661-24-005277 005-86436 241463583 34 90500
2024-11-14 SC 13G/A alyeska-tnxp093024a1.htm 0001172661-24-005273 005-86436 241463532 34 104462
2024-11-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-014604 001-36019 241451474 34 259308 1 1
2024-11-12 10-Q QUARTERLY REPORT 0001999371-24-014569 001-36019 241449787 34 8567763 1 1
2024-11-12 8-K CURRENT REPORT 2.02,9.01 0001999371-24-014466 001-36019 241443551 34 291046 1 1
2024-11-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-038453 001-36019 241441817 34 8749870 1 1
2024-11-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-037168 001-36019 241420757 34 230265 1 1
2024-11-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-036731 001-36019 241417036 34 5300062 1 1
2024-10-30 8-K CURRENT REPORT 5.07 0001999371-24-014188 001-36019 241410800 34 199023 1 1
2024-10-28 8-K CURRENT REPORT 2.02,8.01 0001999371-24-014008 001-36019 241401869 34 204839 1 1
2024-10-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-034021 001-36019 241375944 34 220444 1 1
2024-10-16 SC 13G/A TONIX PHARMACEUTICALS HOLDING CORP. 0000902664-24-005846 005-86436 241373388 34 79619
2024-10-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-033909 001-36019 241373328 34 243039 1 1
2024-10-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-032980 001-36019 241359166 34 231047 1 1
2024-09-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-30 16:00:00 9999999995-24-003043 333-282270 241341071 33 1853
2024-09-27 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-031012 001-36019 241330512 34 242586 1 1
2024-09-26 CORRESP filename1.htm 0001999371-24-012467 10564
2024-09-26 UPLOAD filename1.pdf 0000000000-24-010939 333-282270 40204
2024-09-23 DEF 14A DEFINITIVE PROXY STATEMENTS 0001999371-24-012276 001-36019 241316859 34 235130
2024-09-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-030149 001-36019 241314619 34 43444371 1 1
2024-09-20 S-3 REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS 0001999371-24-012209 333-282270 241314049 33 404753
2024-09-19 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-029804 001-36019 241309075 34 237719 1 1
2024-09-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-029343 001-36019 241299322 34 240237 1 1
2024-09-13 PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-24-011917 001-36019 241298477 34 189862
2024-09-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-028820 001-36019 241288734 34 234694 1 1
2024-09-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-028650 001-36019 241285777 34 22706426 1 1
2024-09-06 8-K CURRENT REPORT 8.01 0001999371-24-011581 001-36019 241285263 34 205845 1 1
2024-08-30 8-K CURRENT REPORT 8.01,9.01 0001999371-24-011157 001-36019 241271003 34 216754 1 1
2024-08-30 424B5 PROSPECTUS 0001999371-24-011155 333-266982 241270961 33 27627
2024-08-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-027198 001-36019 241258540 34 17565281 1 1
2024-08-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-026712 001-36019 241237728 34 231169 1 1
2024-08-20 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-026274 001-36019 241222645 34 234340 1 1
2024-08-19 8-K CURRENT REPORT 2.02,8.01,9.01 0001839882-24-026135 001-36019 241218182 34 305657 1 1
2024-08-16 10-Q QUARTERLY REPORT 0001999371-24-010281 001-36019 241217624 34 8505181 1 1
2024-08-15 NT 10-Q NOTICE UNDER RULE 12B25 OF INABILITY TO TIMELY FILE 0001839882-24-025934 001-36019 241210482 34 21333
2024-08-12 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-009889 001-36019 241194958 34 2803928 1 1
2024-08-09 8-K CURRENT REPORT 2.02,3.01,8.01 0001999371-24-009864 001-36019 241194078 34 210488 1 1
2024-07-30 424B5 PROSPECTUS 0001999371-24-009274 333-266982 241158868 33 363580
2024-07-30 8-K CURRENT REPORT 1.01,9.01 0001999371-24-009272 001-36019 241158682 34 572366 1 1
2024-07-25 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-009017 001-36019 241139891 34 224908 1 1
2024-07-24 8-K/A AMENDMENT TO FORM 8-K 2.06,5.08,9.01 0001999371-24-009003 001-36019 241138993 34 200334 1 1
2024-07-16 8-K CURRENT REPORT 7.01,9.01 0001839882-24-021878 001-36019 241118668 34 13404884 1 1
2024-07-10 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-24-008473 001-36019 241110418 34 1147954 1 1
2024-07-09 424B5 PROSPECTUS 0001999371-24-008420 333-266982 241107800 33 340514
2024-07-08 424B5 PROSPECTUS 0001999371-24-008369 333-266982 241105648 33 349689
2024-07-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-021193 001-36019 241103389 34 224969 1 1
2024-07-01 8-K CURRENT REPORT 1.01 0001839882-24-020329 001-36019 241088118 34 196338 1 1
2024-06-28 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-24-008001 001-36019 241087041 34 1165882 1 1
2024-06-27 424B5 PROSPECTUS 0001999371-24-007882 333-266982 241080310 33 343234
2024-06-26 424B5 PROSPECTUS 0001999371-24-007813 333-266982 241074300 33 348403
2024-06-26 8-K CURRENT REPORT 8.01,9.01 0001999371-24-007804 001-36019 241073580 34 212628 1 1
2024-06-20 SC 13G SCHEDULE 13G 0001079973-24-000916 005-86436 241056107 34 39568
2024-06-20 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-019198 001-36019 241054130 34 231900 1 1
2024-06-14 8-K/A AMENDMENT TO FORM 8-K 9.01 0001999371-24-007476 001-36019 241046087 34 234519 1 1
2024-06-13 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-24-007447 001-36019 241042220 34 859672 1 1
2024-06-12 424B5 PROSPECTUS 0001999371-24-007379 333-266982 241039117 33 337041
2024-06-11 424B5 PROSPECTUS 0001999371-24-007339 333-266982 241036435 33 346589
2024-06-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-018368 001-36019 241031558 34 74821733 1 1
2024-06-06 8-K CURRENT REPORT 3.03,5.03,8.01,9.01 0001999371-24-007198 001-36019 241024258 34 277838 1 1
2024-06-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-018059 001-36019 241023879 34 7508916 1 1
2024-06-03 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-017297 001-36019 241012048 34 6135027 1 1
2024-05-30 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-016704 001-36019 241000772 34 229288 1 1
2024-05-24 4 xslF345X05/treco-form4.xml 0001999371-24-006625 5662
2024-05-24 4 xslF345X05/taylor-form4.xml 0001999371-24-006624 5685
2024-05-24 4 xslF345X05/stillwell-form4.xml 0001999371-24-006623 5700
2024-05-24 4 xslF345X05/olukotun-form4.xml 0001999371-24-006622 5653
2024-05-24 4 xslF345X05/grange-form4.xml 0001999371-24-006620 5523
2024-05-24 4 xslF345X05/bell-form4.xml 0001999371-24-006618 5690
2024-05-24 4 xslF345X05/bagger-form4.xml 0001999371-24-006617 5688
2024-05-22 8-K CURRENT REPORT 2.05,2.06,5.07 0001999371-24-006472 001-36019 24974351 34 220413 1 1
2024-05-22 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-016019 001-36019 24971675 34 230397 1 1
2024-05-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-006367 001-36019 24966880 34 10090626 1 1
2024-05-13 8-K CURRENT REPORT 2.02,9.01 0001999371-24-005990 001-36019 24939971 34 328137 1 1
2024-05-13 10-Q QUARTERLY REPORT 0001999371-24-005989 001-36019 24939910 34 6836843 1 1
2024-04-15 ARS ANNUAL REPORT 0001999371-24-004804 001-36019 24845212 34 790172
2024-04-15 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-24-004802 001-36019 24845139 34 649683
2024-04-05 PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-24-004526 001-36019 24827122 34 649859
2024-04-01 8-K CURRENT REPORT 2.02,9.01 0001999371-24-004298 001-36019 24810022 34 349917 1 1
2024-04-01 10-K ANNUAL REPORT 0001999371-24-004297 001-36019 24809998 34 10812656 1 1
2024-03-29 424B5 PROSPECTUS 0001999371-24-004227 333-266982 24804906 33 444568
2024-03-29 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-24-004225 001-36019 24804804 34 1047366 1 1
2024-03-25 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-008812 001-36019 24777047 34 250475 1 1
2024-03-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-008566 001-36019 24769739 34 789278 1 1
2024-03-20 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-003709 001-36019 24766539 34 242930 1 1
2024-03-19 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-008276 001-36019 24761145 34 249085 1 1
2024-03-11 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-007475 001-36019 24736591 34 232031 1 1
2024-03-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-007193 001-36019 24728203 34 254161 1 1
2024-03-06 4/A AMENDMENT TO STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-24-003168 10377
2024-03-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-007089 001-36019 24724415 34 243459 1 1
2024-03-05 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-006906 001-36019 24718350 34 232848 1 1
2024-02-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001999371-24-002952 10144
2024-02-29 4 BENEFICIAL OWNERSHIP 0001999371-24-002951 7954
2024-02-29 4 CHANGES OF BENEFICIAL OWNERSHIP 0001999371-24-002950 7964
2024-02-29 4 FORM 4 - SULLIVAN 0001999371-24-002949 7950
2024-02-28 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-005811 001-36019 24690264 34 239144 1 1
2024-02-27 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-005612 001-36019 24682060 34 229436 1 1
2024-02-15 8-K CURRENT REPORT 5.07 0001999371-24-002423 001-36019 24644683 34 203294 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 2 0001214659-24-002883 005-86436 24637379 34 82425
2024-02-14 SC 13G armistice-tnxp123123.htm 0001172661-24-001411 005-86436 24637225 34 90445
2024-02-14 SC 13G alyeska-tnxp123123.htm 0001172661-24-001200 005-86436 24635762 34 106737
2024-02-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-004093 001-36019 24622660 34 243258 1 1
2024-02-12 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-003961 001-36019 24617347 34 52628556 1 1
2024-01-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-002578 001-36019 24580619 34 229127 1 1
2024-01-29 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-24-002191 001-36019 24570052 34 221597 1 1
2024-01-25 8-K CURRENT REPORT 5.03,5.07,9.01 0001999371-24-000837 001-36019 24562221 34 2906647 1 1
2024-01-19 8-K CURRENT REPORT 8.01 0001999371-24-000585 001-36019 24546019 34 198242 1 1
2024-01-11 SC 13G p24-0049sc13g.htm 0000902664-24-000180 005-86436 24529796 34 86725
2024-01-08 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-000235 001-36019 24520969 34 8317521 1 1
2024-01-08 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-24-000222 001-36019 24520551 34 199644
2024-01-03 SC 13G TNXP 13G 1.03.24 0001535610-24-000024 005-86436 24506849 34 13327
2024-01-02 8-K CURRENT REPORT 7.01,8.01,9.01 0001999371-24-000016 001-36019 24502588 34 33202565 1 1
2023-12-29 PRE 14A PRELIMINARY PROXY STATMENT 0001999371-23-001322 001-36019 231528449 34 132999
2023-12-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-23-001219 001-36019 231514175 34 276815
2023-12-21 424B5 PROSPECTUS SUPPLEMENT 0001999371-23-001144 333-266982 231506402 33 638543
2023-12-21 424B5 PROSPECTUS SUPPLEMENT 0001999371-23-001138 333-254975 231506171 33 638543
2023-12-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001999371-23-001135 001-36019 231506060 34 1190007 1 1
2023-12-20 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-034226 001-36019 231500077 34 9817973 1 1
2023-12-12 8-K CURRENT REPORT 7.01,9.01 0001839882-23-033451 001-36019 231479930 34 24279063 1 1
2023-12-08 8-K CURRENT REPORT 1.01,2.03,8.01,9.01 0001999371-23-000907 001-36019 231476310 34 559613 1 1
2023-12-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-032560 001-36019 231461304 34 34120567 1 1
2023-11-15 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-030723 001-36019 231409018 34 29973834 1 1
2023-11-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-030370 001-36019 231395036 34 254160 1 1
2023-11-09 10-Q QUARTERLY REPORT 0001839882-23-030328 001-36019 231392998 34 7194568 1 1
2023-11-09 8-K CURRENT REPORT 2.02,9.01 0001839882-23-030323 001-36019 231392921 34 346570 1 1
2023-11-02 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012988 001-36019 231370180 34 15430842 1 1
2023-10-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012958 001-36019 231365566 34 228857 1 1
2023-10-30 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012833 001-36019 231357237 34 7928591 1 1
2023-10-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-028167 001-36019 231347490 34 248716 1 1
2023-10-20 8-K CURRENT REPORT 3.01 0001387131-23-012492 001-36019 231337706 34 195926 1 1
2023-10-20 PRE 14A PRELIMINARY PROXY STATEMENT 0001387131-23-012488 001-36019 231337592 34 210649
2023-10-19 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012387 001-36019 231333345 34 4388870 1 1
2023-10-18 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012338 001-36019 231330905 34 235731 1 1
2023-10-16 8-K CURRENT REPORT 7.01,9.01 0001387131-23-012281 001-36019 231327665 34 30175723 1 1
2023-10-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-012258 001-36019 231326190 34 237343 1 1
2023-10-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-011903 001-36019 231306563 34 233803 1 1
2023-09-29 8-K CURRENT REPORT 1.01,8.01,9.01 0001839882-23-026088 001-36019 231295844 34 1201434 1 1
2023-09-29 424B4 PROSPECTUS 0001839882-23-026084 333-254975 231295820 33 488737
2023-09-28 424B5 PROSPECTUS 0001387131-23-011709 333-254975 231289467 33 491078
2023-09-27 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-011572 001-36019 231281914 34 17457973 1 1
2023-09-25 8-K CURRENT REPORT 7.01,9.01 0001387131-23-011529 001-36019 231276217 34 12851419 1 1
2023-09-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-011424 001-36019 231267720 34 7719701 1 1
2023-09-18 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-011227 001-36019 231260173 34 232285 1 1
2023-09-14 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-011125 001-36019 231254147 34 21729906 1 1
2023-09-11 8-K CURRENT REPORT 7.01,9.01 0001387131-23-011010 001-36019 231246836 34 23551386 1 1
2023-09-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-010815 001-36019 231237836 34 265103 1 1
2023-09-05 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-010769 001-36019 231234120 34 1216526 1 1
2023-08-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-009993 001-36019 231187356 34 20990759 1 1
2023-08-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-009876 001-36019 231176478 34 233948 1 1
2023-08-10 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-23-009623 001-36019 231160346 34 12748065 1 1
2023-08-10 10-Q QUARTERLY REPORT 0001387131-23-009608 001-36019 231159880 34 5881139 1 1
2023-08-07 8-K CURRENT REPORT 7.01,9.01 0001387131-23-009392 001-36019 231148536 34 14059210 1 1
2023-08-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-009352 001-36019 231145767 34 268996 1 1
2023-08-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-009126 001-36019 231129624 34 16641104 1 1
2023-07-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-009043 001-36019 231125156 34 14425445 1 1
2023-07-28 8-K CURRENT REPORT 1.01,8.01,9.01 0001387131-23-009019 001-36019 231123788 34 973449 1 1
2023-07-28 424B5 PROSPECTUS 0001387131-23-009016 333-254975 231123652 33 485817
2023-07-27 424B5 PROSPECTUS 0001387131-23-008845 333-254975 231118570 33 497072
2023-07-27 8-K CURRENT REPORT 8.01,9.01 0001387131-23-008842 001-36019 231118343 34 202431 1 1
2023-07-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-019149 001-36019 231113896 34 14442713 1 1
2023-07-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-008567 001-36019 231103754 34 287879 1 1
2023-07-18 8-K/A AMENDMENT TO FORM 8-K 9.01 0001387131-23-008497 001-36019 231095084 34 555661 1 1
2023-07-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-008472 001-36019 231090501 34 14394021 1 1
2023-07-12 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-008382 001-36019 231083283 34 14300410 1 1
2023-07-10 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-008303 001-36019 231078218 34 268458 1 1
2023-07-03 8-K CURRENT REPORT 1.01,2.01,7.01,9.01 0001387131-23-008172 001-36019 231063595 34 37733992 1 1
2023-06-26 8-K CURRENT REPORT 7.01,9.01 0001387131-23-007865 001-36019 231043075 34 13995370 1 1
2023-06-26 8-K CURRENT REPORT 1.01,7.01,8.01,9.01 0001387131-23-007787 001-36019 231039469 34 11408877 1 1
2023-06-16 S-8 INITIAL REGISTRATION STATEMENT 0001387131-23-007637 333-272746 231022220 33 92609
2023-06-15 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-007575 001-36019 231015940 34 227227 1 1
2023-06-13 8-K CURRENT REPORT 7.01,9.01 0001839882-23-015394 001-36019 231012281 34 8161383 1 1
2023-06-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-007292 001-36019 23997632 34 5830593 1 1
2023-06-05 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-007219 001-36019 23991209 34 24752100 1 1
2023-06-01 8-K CURRENT REPORT 7.01,9.01 0001387131-23-007118 001-36019 23982982 34 10341562 1 1
2023-05-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-007090 001-36019 23978910 34 223890 1 1
2023-05-25 8-K CURRENT REPORT 8.01,9.01 0001387131-23-006919 001-36019 23960805 34 225633 1 1
2023-05-25 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-006868 001-36019 23956177 34 217924 1 1
2023-05-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-006763 001-36019 23946503 34 239661 1 1
2023-05-22 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-006702 001-36019 23942413 34 231841 1 1
2023-05-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-006631 001-36019 23929611 34 8928919 1 1
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012505 5823
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012504 5827
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012503 5658
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012502 5786
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012501 5832
2023-05-10 4 xslF345X04/ownership.xml 0001839882-23-012500 5820
2023-05-10 4 xslF345X04/treco-form4_050823.xml 0001387131-23-006320 5807
2023-05-09 8-K CURRENT REPORT 3.03,5.03,8.01,9.01 0001387131-23-006247 001-36019 23901131 34 2158994 1 1
2023-05-08 10-Q QUARTERLY REPORT 0001387131-23-006175 001-36019 23898204 34 5497046 1 1
2023-05-08 8-K CURRENT REPORT 2.02,9.01 0001387131-23-006126 001-36019 23895820 34 266464 1 1
2023-05-05 8-K CURRENT REPORT 5.07 0001387131-23-006116 001-36019 23894431 34 210354 1 1
2023-05-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-006024 001-36019 23886582 34 226473 1 1
2023-05-01 8-K CURRENT REPORT 7.01,9.01 0001387131-23-005750 001-36019 23869998 34 19127252 1 1
2023-04-19 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004826 001-36019 23828449 34 15475539 1 1
2023-04-17 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004756 001-36019 23822833 34 226829 1 1
2023-04-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004652 001-36019 23817024 34 12546279 1 1
2023-04-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004529 001-36019 23806723 34 11048316 1 1
2023-04-05 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004452 001-36019 23801160 34 229493 1 1
2023-04-04 8-K CURRENT REPORT 3.01,7.01,8.01,9.01 0001387131-23-004420 001-36019 23795081 34 12265559 1 1
2023-03-30 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-004129 001-36019 23777139 34 7848422 1 1
2023-03-29 ARS ANNUAL REPORT 0001387131-23-004065 001-36019 23771600 34 1433179
2023-03-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001839882-23-007387 001-36019 23756705 34 5769686 1 1
2023-03-20 8-K CURRENT REPORT 7.01,9.01 0001387131-23-003690 001-36019 23747075 34 11596973 1 1
2023-03-17 DEF 14A DEFINITIVE PROXY STATEMENT 0001839882-23-007052 001-36019 23743759 34 1088037
2023-03-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-23-006928 5634
2023-03-16 3 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-23-006927 4452
2023-03-16 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-003469 001-36019 23737100 34 250002 1 1
2023-03-13 8-K CURRENT REPORT 7.01,9.01 0001387131-23-003379 001-36019 23728329 34 9180750 1 1
2023-03-13 10-K ANNUAL REPORT 0001387131-23-003377 001-36019 23728290 34 7650463 1 1
2023-03-13 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-23-003349 001-36019 23725673 34 298461 1 1
2023-03-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-002814 001-36019 23711008 34 2321063 1 1
2023-02-27 8-K CURRENT REPORT 7.01,9.01 0001839882-23-004715 001-36019 23670014 34 8802789 1 1
2023-02-24 4 BENEFICIAL OWNERSHIP 0001839882-23-004704 7840
2023-02-24 4 BENEFICIAL OWNERSHIP 0001839882-23-004703 7830
2023-02-24 4 BENEFICIAL OWNERSHIP 0001839882-23-004702 7839
2023-02-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001839882-23-004701 7863
2023-02-23 8-K CURRENT REPORT 5.02,8.01,9.01 0001387131-23-002322 001-36019 23659934 34 219953 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-23-002409 005-86436 23628393 34 83030
2023-02-13 8-K FORM 8-K 7.01,8.01,9.01 0001387131-23-001821 001-36019 23614650 34 232848 1 1
2023-02-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-001625 001-36019 23601083 34 8276969 1 1
2023-02-07 8-K CURRENT REPORT 7.01,9.01 0001387131-23-001486 001-36019 23592741 34 6514319 1 1
2023-02-06 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-001431 001-36019 23588352 34 243520 1 1
2023-02-02 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-001287 001-36019 23578768 34 239270 1 1
2023-02-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-001159 001-36019 23574708 34 8129236 1 1
2023-01-31 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-001054 001-36019 23570211 34 4886431 1 1
2023-01-30 8-K CURRENT REPORT 8.01,9.01 0001387131-23-000880 001-36019 23565170 34 215822 1 1
2023-01-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-000747 001-36019 23558620 34 3426898 1 1
2023-01-25 8-K CURRENT REPORT 2.02,8.01 0001387131-23-000543 001-36019 23549702 34 209331 1 1
2023-01-24 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-23-000513 001-36019 23545854 34 6027567 1 1
2023-01-10 8-K CURRENT REPORT 7.01,9.01 0001387131-23-000188 001-36019 23519667 34 7776679 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (445 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 19.43M 2026-11-06 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
dei EntityPublicFloat Entity Public Float USD 271.37M 2025-06-30 2025 FY 10-K 2026-03-12 0001999371-26-005730
ffd NetFeeAmt NetFeeAmt USD 2,815.31 2026-07-01 S-8 2026-07-01 0001493152-26-031574
ffd TtlFeeAmt TtlFeeAmt USD 2,815.31 2026-07-01 S-8 2026-07-01 0001493152-26-031574
ffd TtlOfferingAmt TtlOfferingAmt USD 20.39M 2026-07-01 S-8 2026-07-01 0001493152-26-031574
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-01 S-8 2026-07-01 0001493152-26-031574
us-gaap AccountsPayable Accounts Payable (Deprecated 2009-01-31) USD 5,240 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 24.63M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 17.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 95 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 14.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AccruedEmployeeBenefitsCurrentAndNoncurrent Accrued Employee Benefits USD 43,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0001387131-21-010869
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.25M 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 227,000 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap AccruedRentCurrent Accrued Rent, Current USD 12,000 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 53,000 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -391,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 59,500 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 1.26M 2020-01-01 2020-03-31 2021 Q3 10-Q 2021-11-08 0001387131-21-010869
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 6.66M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -9.98M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 2.29M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 571,330 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062620
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 896,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 41.00M 2012-01-01 2012-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 26.68M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap AdvertisingExpense Advertising Expense USD 7.60M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.90M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 31,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 65,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 1.84M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AreaOfLand Area of Land acre 40,000 2020-09-28 2020 Q3 10-Q 2020-11-09 0001387131-20-009688
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 58.96M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap Assets Assets USD 242.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AssetsCurrent Assets, Current USD 192.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 23.59M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 7.18M 2016-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 25,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 27,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 8.46M 2015-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 232,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap Cash Cash USD 58.18M 2015-03-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028828
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 162.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 4.54M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -10.81M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 163.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -46.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 142.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 20.00M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028828
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.25 2013-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 641,264 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5,883 2025-12-31 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 19.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 19.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CommonStockValue Common Stock, Value, Issued USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -134.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 4.45M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 5.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent Contract with Customer, Receivable, after Allowance for Credit Loss, Current USD 1.63M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap ConvertibleDebt Convertible Debt USD 2.08M 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap CostOfRevenue Cost of Revenue USD 3.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CostsAndExpenses Costs and Expenses USD 177.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap CustomerRefundLiabilityCurrent Customer Refund Liability, Current USD 11.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 199,250 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 13,750 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 820,000 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap DebtConversionOriginalDebtInterestRateOfDebt Debt Conversion, Original Debt, Interest Rate of Debt pure 0.08 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 5.83M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 710,000 2012-01-01 2012-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.3 2012-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 300,000 2013-08-01 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.08 2012-11-02 2012-11-14 2012 Q3 10-Q 2012-11-14 0001144204-12-062620
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 1.16M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 24,000 2011-01-01 2011-12-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-08 0001144204-14-048073
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 100,916 2013-06-30 2013 Q2 10-Q 2013-08-14 0001144204-13-046004
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 636,000 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap DeferredRentCredit Deferred Rent Credit USD 12,000 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 12,000 2017-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2013-09-30 2013 Q3 10-Q 2013-11-13 0001144204-13-061041
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 82.23M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 55.38M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 6.11M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 9.25M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.61M 2016-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 11.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 388,000 2015-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 82.23M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 400,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.19 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap Depreciation Depreciation USD 43,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -1.18M 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 22.50M 2023-12-22 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 31.89M 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 1.26M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap DueToAffiliateNoncurrent Due to Affiliate, Noncurrent USD 265,000 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 595 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 265,000 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-019081
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -8.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.26 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001387131-22-003640
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -8.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.144 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsExtraterritorialIncomeExclusion Effective Income Tax Rate Reconciliation, Deduction, Extraterritorial Income Exclusion, Percent pure 0.032 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.032 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD 19,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -9,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-12 0001387131-19-005974
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.13M 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 70,000 2014-12-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028828
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-12 0001387131-20-004639
us-gaap EscrowDeposit Escrow Deposit USD 2.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ExplorationExpenseMining Exploration Expense, Mining (Deprecated 2018-01-31) USD 24,111 2007-11-16 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 8,000 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -6.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 1.25 2012-06-30 2012 Q2 10-Q 2012-08-13 0001144204-12-044868
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.957 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-13 0001144204-12-044868
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap FIFOInventoryAmount FIFO Inventory Amount USD 4.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 953,000 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 953,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 715,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 953,000 2023-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 953,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 953,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 10.10M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 120,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 334,000 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 72,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 6.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 62,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -2.09M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.42M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001387131-23-009608
us-gaap Goodwill Goodwill USD 965,000 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 965,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 965,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap GovernmentAssistanceAmount GovernmentAssistanceAmount USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap GovernmentAssistanceAmountCumulativeCurrent GovernmentAssistanceAmountCumulativeCurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap GovernmentAssistanceNonoperatingIncome GovernmentAssistanceNonoperatingIncome USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 1.59M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 9.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 48.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncentiveFromLessor Incentive from Lessor USD 34,000 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -34.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -89.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -21.12M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap IncomeTaxesPaid Income Taxes Paid USD 82,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -26.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 456,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 373,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5,240 2007-11-16 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 9.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 8.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 7,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001615774-17-002349
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 11,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD 0 2007-11-16 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -62,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 13.50M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD 2,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-12 0001387131-19-005974
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 2.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInOtherLoans Increase (Decrease) in Other Loans USD 10,000 2007-11-16 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -73,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.68M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 1.56M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001839882-23-030328
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -7,000 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 199,250 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 120,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 120,000 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 1.10M 2007-06-07 2012-03-31 2012 Q1 10-Q 2012-05-15 0001144204-12-029432
us-gaap InterestExpense Interest Expense USD 3,155 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 89,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 6,183 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001144204-12-062620
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 108,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 89,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap InventoryAdjustments Inventory Adjustments USD 21,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 7.02M 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 3.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InventoryGross Inventory, Gross USD 12.37M 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap InventoryNet Inventory, Net USD 8.41M 2024-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 3.37M 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 1.98M 2024-03-31 2024 Q1 10-Q 2024-05-13 0001999371-24-005989
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 1.37M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InventoryWriteDown Inventory Write-down USD 1.32M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 6,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 19.06M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 23,000 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap LeaseIncentivePayableCurrent Lease Incentive, Payable, Current USD 2.25M 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap LegalFees Legal Fees USD 20,000 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.40M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 480,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 31,000 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 31,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 366,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 451,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 71,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 127,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap Liabilities Liabilities USD 42.94M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 242.43M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap LiabilitiesCurrent Liabilities, Current USD 42.03M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 132,417 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap LoansPayable Loans Payable USD 10,000 2011-06-30 2011 Q2 10-Q 2011-08-15 0001165527-11-000713
us-gaap LoansPayableCurrent Loans Payable, Current USD 10,000 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap LongTermDebt Long-term Debt USD 8.65M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 2.82M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 2.82M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 5.83M 2023-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 5.83M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 705,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 4.67M 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 16.58M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 2.48M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 30.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 75.70M 2025-03-31 2025 Q1 10-Q 2025-05-12 0001999371-25-005875
us-gaap MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure Mortgage-backed Securities Available-for-sale, Fair Value Disclosure USD 19.06M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 81.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 17.40M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001615774-17-004278
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 7.17M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001615774-17-004278
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -125.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -9.15M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001615774-17-004278
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -134.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -134.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Warrants Issued shares 2.68M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 83,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001387131-21-005464
us-gaap NontradeReceivables Nontrade Receivables USD 953,000 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap NontradeReceivablesCurrent Nontrade Receivables, Current USD 2.13M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap NotesIssued1 Notes Issued USD 320,000 2012-10-01 2012-11-14 2012 Q3 10-Q 2012-11-14 0001144204-12-062620
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OperatingExpenses Operating Expenses USD 14.01M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -139.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 200,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.27M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 338,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 915,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OperatingLeasePayments Operating Lease, Payments USD 231,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 596,000 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 136,000 2017-09-30 2017 Q3 10-Q 2017-11-06 0001615774-17-006255
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 98,758 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6,000 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6,000 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 284,000 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 181,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063388
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 306,000 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap OperatingLeasesIncomeStatementLeaseRevenue Operating Leases, Income Statement, Lease Revenue USD 9,420 2011-01-01 2011-01-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 500,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.055 2026-06-30 2026 Q2 10-Q 2026-08-10 0001999371-26-017452
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.13M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 4.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OtherCommitment Other Commitment USD 61.40M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001387131-22-011157
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD -8,000 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001387131-21-008266
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 6,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1,000 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap OtherIncome Other Income USD 2,000 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.94M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 5.95M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock Payments for Repurchase of Redeemable Convertible Preferred Stock USD 47.25M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-08 0001144204-14-048073
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 3.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 22.17M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 120,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 28.64M 2015-01-01 2015-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 2.01M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 6.66M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 74,541 2012-06-30 2012 Q2 10-Q 2012-08-13 0001144204-12-044868
us-gaap PrepaidInsurance Prepaid Insurance USD 318,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PrepaidInterest Prepaid Interest USD 523,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap PrepaidTaxes Prepaid Taxes USD 309,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable USD 853,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.89M 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 81.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 27.25M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0001387131-22-008503
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 6.98M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 40.59M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001999371-24-004297
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 227,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 79,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 22.57M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 300,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001387131-20-007238
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 72,354 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.02M 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 8.94M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap ProceedsFromOtherDeposits Proceeds from Other Deposits USD 0 2007-06-07 2011-12-31 2011 FY 10-K 2012-03-30 0001144204-12-019081
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 16.98M 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap ProceedsFromOtherShortTermDebt Proceeds from Other Short-term Debt USD 480,000 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 7.17M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 4.78M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 999,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 52,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0001387131-23-003377
us-gaap ProfessionalFees Professional Fees USD 28,970 2007-11-16 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 4.00M 2020-09-27 2020-09-28 2020 Q3 10-Q 2020-11-09 0001387131-20-009688
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 52.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 44.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units Number 6 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 31,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 1.56M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001839882-23-030328
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 6.66M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001387131-23-003377
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 53,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 100,000 2014-08-01 2014-08-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 80,000 2014-08-01 2014-08-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 150,000 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 9.65M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 63.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap RestrictedCash Restricted Cash USD 388,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 99,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 31.50M 2022-06-30 2022 Q2 10-Q 2022-08-08 0001387131-22-008503
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 240,000 2021-12-31 2021 FY 10-K 2022-03-14 0001387131-22-003640
us-gaap RestrictedCashAndInvestmentsCurrent Restricted Cash and Investments, Current USD 89,000 2018-06-30 2018 Q2 10-Q 2018-08-13 0001615774-18-007871
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 31.50M 2022-06-30 2022 Q2 10-Q 2022-08-08 0001387131-22-008503
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 31.50M 2022-06-30 2023 Q2 10-Q 2023-08-10 0001387131-23-009608
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 388,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -988.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 37.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 8.60M 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.13M 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.85 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap SalesCommissionsAndFees Sales Commissions and Fees USD 40,000 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap SecurityDeposit Security Deposit USD 19,000 2021-12-31 2021 FY 10-K 2022-03-14 0001387131-22-003640
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 110.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 200,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063388
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 39.83M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-13 0001387131-19-003509
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 5,237 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 4.6 2011-01-01 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 11,250 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-09 0001615774-18-001762
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.93 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0 2011-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001387131-19-002012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.493 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.484 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.326 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-11 0001999371-26-010486
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.045 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.02 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 1 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 42,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001144204-15-063388
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 520,228 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16,695 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2012-01-01 2012-12-31 2012 FY 10-K/A 2013-11-22 0001144204-13-063785
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 258,907 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 161,190 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001144204-15-012769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.08 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001387131-21-008266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.13B 2015-12-31 2016 FY 10-K 2017-04-13 0001615774-17-001665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3,908 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 359,466 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 10.21M 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 2.93 2020-12-31 2020 FY 10-K 2021-03-15 0001387131-21-003550
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 662,296 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 109,036 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 199.57 2019-12-31 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 6.37 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap SharePrice Share Price USD/shares 3.21 2018-03-31 2018 Q1 10-Q 2018-05-11 0001615774-18-003618
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 199.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares shares 4.10M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2019-10-29 2019-11-01 2019 FY 10-K 2020-03-24 0001387131-20-003189
us-gaap StockIssued1 Stock Issued USD 3,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008474
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 54,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001615774-18-012342
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 245,205 2024-06-01 2024-06-10 2024 FY 10-K 2025-03-18 0001999371-25-002786
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 5,128 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 2.63M 2007-06-07 2014-03-31 2014 Q1 10-Q 2014-05-13 0001144204-14-030020
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 201,000 2009-01-01 2009-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 148,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 144,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-28 0001144204-14-018823
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 28.10M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 608,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-03 0001144204-16-085821
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001144204-16-099576
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 36,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 400,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 2.90M 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 250,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001999371-25-005875
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 13.96M 2023-01-01 2023-03-31 2024 Q3 10-Q 2024-11-12 0001999371-24-014569
us-gaap Supplies Prepaid Supplies USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2023-06-30 2023 Q2 10-Q 2023-08-10 0001387131-23-009608
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 5.00M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001387131-23-009608
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 14.84 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 19.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD -2.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 13.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 29.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 21.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 1,056 2024-05-21 2024-05-22 2025 FY 10-K 2026-03-12 0001999371-26-005730
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 16.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 360.22M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001387131-22-003640
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 5.50M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-10-07 0001165527-11-000924
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 16.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001999371-26-024873

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →